Local injection of Toll-like receptor agonists or of selected chemokines via the modification of the expression of selectins, integrins, and chemokines could also enhance the recruitment of CD8+ T cells in the tissue and at local tumor site. This evidence concerns the gene CD8A and neoplasm.